{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:27:53Z","timestamp":1767842873402,"version":"3.49.0"},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2004,9,9]],"date-time":"2004-09-09T00:00:00Z","timestamp":1094688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The upfront application of molecular methods for identifying the fusion transcripts arising from balanced translocations in haematopoietic malignancies has several advantages: sensitivity is independent of its frequency, i.e. rare ones are not missed, cytogenetically cryptic aberrations are identified and it provides a platform for minimal residual disease (MRD) detection. Employing a multiplex reverse transcription polymerase chain reaction (RT\u2010PCR) assay identifying 27 fusion transcripts we prospectively analysed blood and\/or bone marrow samples from 390 patients referred for diagnosis and treatment for acute leukaemia and chronic myeloproliferative disorders (CMPD) from a geographically well\u2010defined region in Denmark. A total of 233 patients were diagnosed with acute myeloid leukaemia (AML), 95 with acute lymphoblastic leukaemia (ALL) origin and 62 patients were recorded as CMPD. Twenty\u2010three percent AML, 32% ALL and 55% CMPD patients exhibited chromosomal aberrations detected by the multiplex RT\u2010PCR. Cytogenetically cryptic translocations were seen in 15% of the cases. Conversely, the cytogenetic analysis identified chromosomal aberrations other than translocations in 45% of AML cases and 63% of ALL cases. We conclude that, while the fraction of translocation positive leukaemia patients in an unselected cohort is lower than hitherto believed, a molecular approach to their diagnosis is worthwhile, partly for identifying cryptic and rare translocations, partly for monitoring MRD.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2004.05161.x","type":"journal-article","created":{"date-parts":[[2004,9,22]],"date-time":"2004-09-22T15:40:17Z","timestamp":1095867617000},"page":"59-66","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Prospective application of a multiplex reverse transcription\u2010polymerase chain reaction assay for the detection of balanced translocations in leukaemia: a single\u2010laboratory study of 390 paediatric and adult patients"],"prefix":"10.1111","volume":"127","author":[{"given":"Lene Hyldahl","family":"Olesen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreja","family":"Dimitrijevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gitte","family":"Kerndrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eigil","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hokland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,9,9]]},"reference":[{"key":"e_1_2_19_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403136"},{"key":"e_1_2_19_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402050"},{"key":"e_1_2_19_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.7.2526"},{"key":"e_1_2_19_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(02)80606-2"},{"key":"e_1_2_19_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428190009148847"},{"key":"e_1_2_19_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403135"},{"key":"e_1_2_19_8_1","first-page":"4876","article-title":"Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia","volume":"90","author":"Grimwade D.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_19_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.7.2322"},{"key":"e_1_2_19_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.12.4933"},{"key":"e_1_2_19_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402347"},{"key":"e_1_2_19_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.10.2970.2970"},{"key":"e_1_2_19_13_1","volume-title":"An International System for Human Cytogenetic Nomenclature","author":"ISCN","year":"1995"},{"key":"e_1_2_19_14_1","article-title":"Incidence and outcome of pediatric patients with TEL\/AML1 positive acute lymphoblastic leukemia treated on Dana\u2010Farber Cancer Institute ALL Consortium Protocol 95\u201301","author":"Loh M.L.","year":"2003","journal-title":"Blood"},{"key":"e_1_2_19_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(02)00075-9"},{"key":"e_1_2_19_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.13.7521"},{"key":"e_1_2_19_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(00)00235-1"},{"key":"e_1_2_19_18_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2003.00060.x"},{"key":"e_1_2_19_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.2.574"},{"key":"e_1_2_19_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199912)26:4<355::AID-GCC10>3.0.CO;2-3"},{"key":"e_1_2_19_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1986.tb00816.x"},{"key":"e_1_2_19_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2000.02474.x"},{"key":"e_1_2_19_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V47.5.705.705"},{"key":"e_1_2_19_24_1","first-page":"2517","article-title":"Molecular quantification of response to therapy and remission status in TEL\u2010AML1\u2010positive childhood ALL by real\u2010time reverse transcription polymerase chain reaction","volume":"61","author":"Seeger K.","year":"2001","journal-title":"Cancer Research"},{"key":"e_1_2_19_25_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2001.00556.x"},{"key":"e_1_2_19_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.3.805"},{"key":"e_1_2_19_27_1","unstructured":"Guidelines for Clinical Cytogenetics Supplement to an International System for Human Cytogenetic Nomenclature(1995)S Karger Basel"},{"key":"e_1_2_19_28_1","volume-title":"Professional Guidelines for Clinical Cytogenetics","author":"The Professional Standard Working Party and the Association of Clinical Cytogeneticists","year":"2001"},{"key":"e_1_2_19_29_1","first-page":"810","article-title":"Clinical significance of MLL\u2010AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation","volume":"92","author":"Uckun F.M.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_19_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400571"},{"key":"e_1_2_19_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0531"},{"key":"e_1_2_19_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(81)80063-9"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05161.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05161.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2004.05161.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:43:59Z","timestamp":1697417039000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2004.05161.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,9]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1365-2141.2004.05161.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05161.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,9]]},"assertion":[{"value":"2004-09-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}